Funds & Shareholders

Minimize

SEED Capital invests from subsequent funds with a fixed life time span of 10-12 years. These funds are raised with 4-5 years between them and the limited partners, who invest into SEED Capital funds, consist of a number of large enterprises and asset management companies as well as private investors, normally referred to as friends & family.

Each fund has an Investor Board who is decision maker on all fund-related issues besides investments and an Investor Committee who is sparring partner and joint decision-maker on investments together with SEED Capitals partner team.

The private and financial investors include Vaekstfonden, ATP, Finanssektorens Pensionskasse, Realdania, Nordea Liv & Pension, Lønmodtagernes Dyrtidsfond, Danske Bank, Nordea Bank, DTU Innovation, Kirkbi, Carlsberg, Danfoss, Danisco, Novo and Radiometer.

SEED Capital Denmark II

Fund size: € 91 million
Management: Managing Partner Ulla Brockenhuus-Schack
Investment period ends: 31.1.2014 (+1 year)
Fund expires: 31.12.2020 (+3 years)

    Investors
  • ATP
  • Vækstfonden
  • Realdania
  • C.L. Davids Fond
  • Augustinus Fonden
  • DTU Symbion Innovation
  • General Partners
  • Friends & Family
    Investment Committee
  • Karsten Knudsen, Chairman
  • Klaus Eldrup-Jørgensen
  • Preben Damgaard
  • Ulla Brockenhuus-Schack
  • Lars Andersen
    Investor Board
  • Edvard Fång (Vækstfonden)
  • Jesper Voss Hansen (ATP)
  • Gert Poulsen (Realdania)

     

    SEED Capital Denmark I

    Fund size: € 71 million
    Management: Managing Partner Ulla Brockenhuus-Schack
    Fund expires: 1.12.2014 (+2 years) Investment period ended

      Investors
    • Vækstfonden
    • ATP Private Equity K/S
    • Nordea Pension
    • Nordea Bank Danmark A/S
    • Kirkbi A/S
    • LD Pensions
    • Fonden Realdania
    • Finanssektorens Pensionskasse
    • Danske Bank A/S
    • DTU Symbion Innovation A/S
    • B&MC Holding A/S (Danfoss)
    • Carlsberg A/S
    • Danisco A/S
    • Novo A/S
    • DANRAD Holding ApS (Radiometer)
    • General Partners
    • Friends & Family
      Investment Committee
    • Karsten Knudsen, Chairman
    • Klaus Eldrup-Jørgensen
    • Preben Damgaard
    • Ulla Brockenhuus-Schack
    • Lars Andersen
      Investor Board
    • Michael Dyrlund (FSP)
    • Lars Eskesen (Nordea & Kirkby)
    • Erik G. Hansen
    • Edvard Fång (Vækstfonden)
    • Jesper Voss Hansen (ATP)
    • Hans Jørgen Madsen (LD)
    • Gert Poulsen (Realdania)

    DTU Symbion Innovation

    DTU Symbion Innovation is a Danish innovation incubator (innovationsmiljø) owned by DTU (Danish Technical University). Like the five other Danish innovation incubators DTU Symbion Innovation invest government capital on behalf of the Danish Agency for Science, Technology and Innovation.

    SEED Capital has a strategic collaboration with DTU Symbion Innovation. Read more at www.dtusymbioninnovation.dk.

    Fund size: € 8 million annually. Appropriation until 2013
    Management: Managing Partner Ulla Brockenhuus-Schack

      Board
    • Erik G. Hansen
    • Anders Bjarklev
    • Preben Damgaard
    • Jørgen Honoré
    • Søren Knud Carlsen

     

    Achievements

    DVCA awardSince 2004 SEED Capital has grown from to be the largest early stage venture fund in Denmark with 200 million € under management. Today 13 investment professionals manage our portfolio of 60+ companies.

    Within our lifespan we’ve managed to produce 12 positive exits and 1 IPO. Most significant being the sale of Fullrate to TDC in 2009 and the listing of Evolva on the Swiss Stock Exchange.

    SEED Capital was awarded Venture Capital Firm of the Year 2010 by Danish Venture Capital & Private Equity Association (DVCA).

    Exits

    SEED Capital has exited a number of interesting companies to global corporations, business angels and management buyouts.

    Minimize

    Evolva

    Drug candidates based on natural products

    www.evolvabio.comNeil Goldsmith (CEO), Prof. Dr. Erich Schlick (CoB)
    Technology: 

    Evolva develops novel genetic pathways leading to new drug candidates for the Healthcare industry. The patented Watchmaker® technology captures nature’s genetic chemistry pool and combines it with an evolutionary process leading to discovery and optimization of novel small molecules for therapeutic targets.

    Value Proposition: 

    The pharmaceutical industry has largely stopped exploring conventional natural products. Natural structures are typically difficult to source, difficult to identify, difficult to analog and difficult to manufacture. However, Nature is still the most efficient supplier of long lasting healthcare ingredients. Evolva´s Watchmaker® technology creates new combinations of synthetic structured products leading to new compounds that interact with the most productive functionalities of natural products. By mixing millions of genes from multiple species such as sponges, humans & plants, Watchmaker® creates long lasting solutions for patients with lifelong conditions.

    Evolva is listed on the Swiss Stock Exchange as Evolva Holding SA.

     

    Portfolio Manager: 

    2cureX

    2cureX exited through sale to new investors in 2011

    www.2curex.com Ole Thastrup (CEO)
    Technology: 

    2curex's novel and patented technology ChemoCellomics® uniquely integrates chemistry and cell screening. The technology allows prospective testing of large collections of individual drugs or combinations thereof in cells from individual cancer patients.

    Kaleido Technology

    Kaleido shares was acquired by AAC Acoustic in 2011

    Technology: 

    Kaleido Technology is a manufacturer of integrated micro-optical components and sub-systems for applications in telecom, sensor and material processing. The solution enables the creation of free form aspheric mirrors and lenses with unprecedented properties when it comes to form accuracy, component size, and geometry.

    Wecapack

    Wecapack exited through management buy-out in 2010

    Swantec

    Swantech exited through management buy-out in 2008

    TagAway Devices

    Health care

    Carsten Fredsbo (CEO)
    Technology: 

    TagAway Devices ApS has granted an exclusive license to a large international consumer health care company for its patented technology.

     

    Portfolio Manager: 

    Virogates

    Virogates exited through management buy-out in 2007

    Image Metrology

    Image Metrology exited through management buy-out in 2007

    Dralle

    Dralle exited through sales of shares to new investors in 2007

    Orthometer

    Orthometer exited through UK investor buy-out in 2004

    Collaborations

    Minimize
    One of Japans largest venture firms.
    Vækstfonden is a state investment fund, which aims to create new growth companies by providing venture capital and competence.
    DK venture firm investing mostly in Life Science.
    Health care venture firm investing in life science and medical technology companies at all stages of development
    DK venture capital firm. Invests in IT and Life Science
    Belgian venture arm of the chemical group Solvay focused on leading edge advanced technologies. Invests in funds of funds as well as directly into early stage companies.
    Norweigan venture firm investing in cleantech and life science in the Nordics.
    Venture arm of DK pharma company Novo Nordisk
    Early stage venture arm of DK pharma company Novo Nordisk.
    Venture arm of Novartis focused on the development of novel therapeutics and platforms.
    European Venture Capital Partnership focused on the Nordics. Invests in IT.
    DK based venture capital firm investing in IT
    A private fund providing financing for entrepreneurs for development, legal, production or marketing.
    A fund with a public benefit and charitable purpose. Supports actitivities that promote good living.
    DK private equity firm also managing funds from the government initiated pension fund LD.
    Commercial foundation designed to maintain and expand the activities of the Lundbeck Group, and to provide funding for scientific research of the highest quality.
    French venture capital firm focused on innovative technologies, in particular within sea, aeronautics, the life sciences and information technologies.
    An alliance management company specializing in expanding markets for new and growing companies by creating, launching, and managing collaborative alliances or “business ecosystems".
    European venture capital fund focused on renewable energy. Based in Germany.
    Norweigan industry group with large venture arm.
    A collaboration between three Danish Universities to facilitate technology transfer.
    University of Southern Denmark. Situated in Odense.
    Swedens centre for certain specialised care, especially in paediatrics.
    National laboratory for Sustainable Energy. Part of Danish Technical University
    Copenhagen University
    Copenhagen IT Univeristy
    Denmarks Technical University
    Faculty of Pharmaceutical Sciences at Copenhagen University. Drugs constitute the core in all the Faculty’s research and education.
    The Faculty of Life Sciences (LIFE) at Copenhagen Univesity is one of Europe's leading university environments in the areas of veterinary medicine, food, health, plants, biotechnology, natural resources, the environment and related academic areas.
    Copenhagen Business School
    Aalborg Universty
    Århus School of Business
    Århus University
    Science park and business accelerator
    Denmarks largest science park and the home of SEED Capital.
    Corporate accounting firm.
    Gorissen Federspiel - corporate law firm.
    The association of Science Parks and Innovation Incubators (Innovationsmiljøer)
    The Ministry of Science, Innovation and Higher Education. Grants funds to all six innovation incubators.
    European Private Equity and Venture Capital Association
    Danish Venture Capital and Private Equity Association
    Award winning graphics designer who has helped several portfolio companies set up logo, website, etc. Also designed the updated SEED Capital logo.
    Innovation Incubator based in Århus.
    Innovation Incubator based in Odense, Taastrup and Sønderborg.
    Innovation Incubator based in Aalborg. Is also a Science Park.
    Innovation Incubator based in Herning
    DTU Symbion Innovation is Denmark’s largest and most effective pre-seed venture capital investor (innovationsmiljø) established to finance and assist talented entrepreneurs in developing the companies of the future.
    Innovation Incubator based in Roskilde. Is also a science park and small venture fund.
    Væksthusene. Government funded regional offices offering events and advice to start-ups.
    A venture competition for students at Danish Universities.
    An initiative to support technology transfer from all regional hospitals.
    A non-profit initiative focused on bringing together Europe's Entrepreneurs, Investors and Industry players.
    A 54 hour workshop where you invent, build and present a startup concept from scratch.
    A European Accelerator focused on web/IT
    Entrepreneurship initiative at Copenhagen Business School and Danish Technical University.
    Helps public research institutions secure attractive long term returns on the commercialization of its research and intellectual property.
    50 promising presenting before an audience of Nordic and international venture capital, corporate investors and strategic partners.
    International Open Community platform for mobile
    Initiative to support innovation and entrepreneurship at the Life Science faculties at Copenhagen University.
    The Danish National Advanced Technology Foundation. Offers funds for developing new and important technologies
    The Danish Foundation for Entrepreneurship - Young Enterprise helps ensure that more students on every education level are introduced - and participate in - entrepreneurship education.
    Private company helping cleantech companies apply for private and public funding.
    150 of Europe’s top start-ups in the areas of ICT, Life Sciences and Cleantech
    An independent research based company focused on developing and marketing advanced technology (electronics, light, optics, acoustics, vibrations, sensors).
    Copenhagen Spin-outs work to commercialise scientific achievements by spinning out companies from a number of Danish universities.
    An independent non-profit organization that uses a comprehensive network to advice start-ups with growth potential.
    An independent, research-based service company within biomedicine, biomedical technology and biotechnology.
    Denmarks largest start-up accelerator. Also manages a venture fund and several other start-up initiatives.
    Open Source Lab at CBS.
    The leading interest group and labour association for organised IT Professionals in Denmark
    The largest open source IT-conference in the Nordic area
    A membership organization for the Danish energy industry.
    A membership organization for Danish Biotech companies (drug development and industrial biotechnology).
    One of the largest global cleantech clusters dedicated to providing necessary business conditions to aid cleantech research, development and implementation. Facilitates partnerships, host events, carry out analyses and gathers information.
    Private company providing events and advisory services to accelerate market adoption, stimulate demand, and remove barriers to cleantech innovation.
    An independent network organization for entrepreneurs and business professionals in the healthcare industry, based on the personal interaction between its members.

    Social Capital

    SEED Capital sponsors the Orchid Project.

    The SEED Capital team is encouraged to invest their time in beneficiary projects. Currently we are involved in:

    Mary Fonden Refugees United Oticon Fonden
    Maternaity Worldwide Better Now